Generic Immunosuppressive Drugs After Lung Transplantation
NCT01889017 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2013-07-16
Summary
Extent of use of generics immunosuppressive drugs in clinical practice after lung transplantation
Conditions
- Immunosuppressive After Lung Transplantation
Interventions
- OTHER
-
patient questionnaire (tablet pc based)
Sponsors & Collaborators
-
Hannover Medical School
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-09-30
Countries
- Germany
Study Locations
More Related Trials
-
Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation
NCT00930241 ·Status: TERMINATED ·Phase: PHASE3
-
Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients
NCT05001074 ·Status: UNKNOWN ·Phase: PHASE3
-
Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.
NCT02278952 ·Status: COMPLETED
-
Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
NCT00717379 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective Study
NCT04444817 ·Status: UNKNOWN
-
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
NCT00355862 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
NCT02251691 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics
NCT00902980 ·Status: COMPLETED
-
Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
NCT01678937 ·Status: COMPLETED
-
Comparison of Sirolimus and Azathioprine in Lung Transplantation
NCT00321906 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
NCT06354179 ·Status: RECRUITING ·Phase: PHASE4
-
Adherence to Immunosuppressive Therapy Liver Transplant Recipients
NCT01959308 ·Status: UNKNOWN
-
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
NCT00105235 ·Status: COMPLETED ·Phase: PHASE2
-
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
NCT01517984 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
NCT00204191 ·Status: UNKNOWN ·Phase: PHASE4
-
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients
NCT03558373 ·Status: COMPLETED
-
Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients
NCT05872815 ·Status: UNKNOWN
-
Immunosuppressants to Postoperative Infection and Death
NCT06121804 ·Status: RECRUITING
-
A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients
NCT01014442 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
NCT01136395 ·Status: COMPLETED ·Phase: PHASE2
-
Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)
NCT01381432 ·Status: COMPLETED
-
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.
NCT06147648 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
NCT00135694 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
NCT02453867 ·Status: UNKNOWN ·Phase: PHASE4
-
Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
NCT01429844 ·Status: COMPLETED ·Phase: PHASE3